Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA)

SUNPHARMA Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 6, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	4,377,707	3,888,242	2,358,729	2,194,737	1,434,322	845,286
Market Cap Growth	44.63%	64.84%	7.47%	53.02%	69.68%	-26.43%
Enterprise Value	4,253,935	3,792,904	2,296,495	2,136,376	1,424,670	852,641
Last Close Price	1824.55	1615.43	971.00	893.83	578.03	337.06
PE Ratio	42.13	40.49	27.51	65.72	47.77	21.48
PS Ratio	8.89	8.02	5.37	5.68	4.28	2.57
PB Ratio	6.88	5.79	3.98	4.30	2.90	1.72
P/FCF Ratio	-	39.14	82.08	29.30	28.69	16.86
P/OCF Ratio	-	32.04	47.56	24.43	23.25	12.90
EV/Sales Ratio	8.64	7.82	5.23	5.53	4.25	2.60
EV/EBITDA Ratio	31.99	29.46	19.71	21.04	17.07	12.44
EV/EBIT Ratio	39.38	36.05	24.68	26.19	22.16	17.23
EV/FCF Ratio	-	38.18	79.91	28.52	28.49	17.01
Debt / Equity Ratio	0.05	0.05	0.12	0.03	0.08	0.17
Debt / EBITDA Ratio	0.25	0.25	0.58	0.13	0.46	1.20
Debt / FCF Ratio	-	0.33	2.40	0.17	0.77	1.66
Asset Turnover	-	0.58	0.58	0.56	0.49	0.49
Inventory Turnover	-	1.08	1.12	1.17	1.05	1.17
Quick Ratio	-	1.82	1.36	1.37	1.20	1.36
Current Ratio	-	2.56	2.00	2.03	1.89	2.02
Return on Equity (ROE)	-	15.20%	15.42%	6.74%	4.61%	8.89%
Return on Assets (ROA)	-	7.91%	7.73%	7.42%	5.91%	4.65%
Return on Capital (ROIC)	9.93%	9.63%	9.81%	9.64%	7.25%	5.49%
Earnings Yield	2.37%	2.46%	3.59%	1.49%	2.02%	4.45%
FCF Yield	2.55%	1.22%	3.41%	3.49%	5.93%
Dividend Yield	0.74%	0.84%	1.18%	1.12%	1.30%	1.19%
Payout Ratio	0.00%	30.26%	29.73%	65.97%	53.70%	36.63%
Buyback Yield / Dilution	0.17%	-	-	-	-	-0.00%
Total Shareholder Return	0.91%	0.84%	1.18%	1.12%	1.30%	1.19%

Source: S&P Capital IQ. Standard template. Financial Sources.